[AI pharmaceutical concept rebounded with shock and Bepsis rose more than 10%] On October 28, the AI ​​pharmaceutical concept rebounded in shock in early trading, with Bepsis rising by more than 10%, and Northrop Grumpy, Yiqiao Shenzhou, Hualan, Medicilon, Hengrui Pharmaceuticals, and Hongbo Pharmaceuticals all rose by more than 5%. On the news, on October 28, Anthropic announced that its life sciences team has established in-depth research cooperation with six new drug research and development institutions, including Bristol-Myers Squibb and Generate Biomedicines, and has launched independent drug discovery projects. The first direction is rare childhood muscular dystrophy, with Claude responsible for most of the scientific and operational work.